1.4 million fewer people enrolled in ACA plans as premiums spike, tax credits expire

ACA marketplace enrollment is down roughly 1.4 million year-over-year with 22.8 million consumers selecting plans versus 24.2 million at the same point last year (2.8M new customers now vs 3.9M prior). The decline is tied to the expiration of enhanced premium tax credits, political deadlock during the recent shutdown and stalled Senate action; the CBO projects gross benchmark premiums could rise 4.3% in 2026 and 7.7% in 2027, while a KFF analysis estimates subsidized consumers could see average premiums jump ~114% from $888 in 2025 to $1,904 in 2026. House Democrats passed a bill to extend the credits for three years, but extension remains uncertain.

Analysis

Market structure: The 1.4M decline in ACA selections and KFF’s 114% avg premium jump for subsidy recipients (to ~$1,900 in 2026) creates clear winners and losers: diversified payers with heavy Medicare Advantage/Commercial lines (UNH, ELV, CI) gain relative pricing power, while exchange-dependent carriers (Centene CNC, Molina MOH) face immediate volume and margin pressure. CBO’s 4.3%/7.7% gross premium rise forecasts for 2026/27 imply higher ARPU but material enrollment elasticity, so net revenue depends on subsidy policy and enrollment churn.

Risk assessment: Key tail risks are a) Congressional extension of enhanced premium tax credits within 30–60 days (large positive shock to exchange carriers), b) state-level measures expanding Medicaid or shifting risk, and c) deterioration in hospitals’ cash flows raising muni/hospital bond spreads. Immediate (days): Jan 15 enrollment deadline volatility; short-term (weeks–months): legislative votes and Q1 2026 premium notices; long-term (quarters): 2026–27 realized premium resets and loss ratios.

Trade implications: Favor relative-long positions in highly diversified insurers (UNH, ELV) and short/hedge positions on CNC and MOH into the legislative window; use directional equity and option structures to express convexity around a binary subsidy outcome. Cross-asset: expect modest widening in IG healthcare credit spreads and select muni hospital stress if uncompensated care rises; FX/commodities minimal.

Contrarian angles: Consensus assumes permanent enrollment decline — that’s overstated absent multi-month subsidy expiration; historical policy fights (2017–2020) caused transient price dislocations but earnings reversion once policy clarified. If Congress signals even a 1-year bridge within 60 days, exchange names could re-rate sharply; consider small, cheap long option punts as asymmetric upside.

Key Decisions for Investors

• Establish a 2–3% portfolio long in UnitedHealth (UNH) and/or Elevance Health (ELV) combined (e.g., 1.5% UNH, 1.5% ELV) within 5 trading days to capture relative resilience from Medicare Advantage and diversified revenue; target +12–20% upside over 3–12 months, stop-loss at -8%.
• Enter shorts totaling 1.5–2.5% of portfolio in Centene (CNC) and Molina (MOH) (ratio 2:1 CNC:MOH) via cash equities or borrow within the next 10 trading days to capitalize on enrollment/margin risk if subsidies lapse; cover or reassess within 60 days of any congressional extension vote.
• Buy protective 3–6 month puts (10% OTM) on CNC and MOH sized to 0.5–1.0% of portfolio cost as a cheap asymmetric hedge against downside if enrollment drops further; alternatively sell 1–2 month covered calls on UNH/ELV to fund hedges if volatility rises >20% IV.
• Prepare a contingency to flip short positions into long call spreads on CNC/MOH (6–12 month 15–25% OTM call debit spreads) if Congress votes to extend enhanced credits within 30–60 days — allocate up to 0.5% portfolio to this upside punt and set execution trigger on official legislative calendar events or CBO score publication.